3WM-30995-75277 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-09-17
Registered in v-safe
2021-09-17
Dose 1 — Pfizer-BioNTech
2021-09-17
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-09-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-09-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-09-20
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Fair

Free text: Dizziness

MedDRA releases: 2024-11 · check-in free text available
2021-09-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Joint pains

Adult check-in
2021-09-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-09-23
Survey response — days 1–6 daily, dose 1
MedDRA: Anxiety — Feeling: Good · Joint pains

Free text: Increased anxiety

MedDRA releases: 2024-11 · check-in free text available
2021-09-24
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-10-01
Survey response — day 14, dose 1
MedDRA: Anxiety — Feeling: Fair

Free text: Increased feeling of anxiousness

MedDRA releases: 2024-11 · check-in free text available
2021-10-08
Dose 2 — Pfizer-BioNTech
2021-10-08
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-10-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain

Adult check-in
2021-10-10
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness

Adult check-in
2021-10-11
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Headache · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2021-10-11
Report sent to call center — days 1–6 daily, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-10-12
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · None

Adult check-in
2021-10-13
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea — Feeling: Fair

Free text: Shortness of breath

MedDRA releases: 2024-11 · check-in free text available
2021-10-14
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fever · None

Adult check-in
2021-10-15
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-10-15
Call 1 — Left Voicemail
2021-10-22
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-10-29
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-11-05
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-11-14
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-11-19
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2022-01-08
Survey response — 3 months, dose 2
MedDRA: Polymorphic eruption of pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: 38 weeks pregnant, developed a PUPP rash all over my body, been taking medicine, feeling baby move less.

MedDRA releases: 2024-11 · check-in free text available
2022-01-08
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-01-11
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-09-17	Pfizer-BioNTech	No
2	2021-10-08	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-10-11	Successful	Participant prefers to complete VAERS report online
2022-01-08	Successful 2022-01-11	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 9 — days 1–6 daily, dose 1

2021-09-20

Systemic reaction (other): Dizziness

2021-09-23

Systemic reaction (other): Increased anxiety

Release 9 — day 14, dose 1

2021-10-01

Symptoms: Increased feeling of anxiousness

Release 10 — days 1–6 daily, dose 2

2021-10-13

Systemic reaction (other): Shortness of breath

Release 10 — 3 months, dose 2

2022-01-08

Symptoms: 38 weeks pregnant, developed a PUPP rash all over my body, been taking medicine, feeling baby move less.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anxiety	·	·	✓
SD	Polymorphic eruption of pregnancy	·	·	✓
SRO	Anxiety	·	·	✓
SRO	Dizziness	·	·	✓
SRO	Dyspnoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release